CENP-A, an essential centromere protein, is a prognostic marker for relapse in estrogen receptor-positive breast cancer Full Text
Breast Cancer Research,

McGovern SL et al. – Centromere protein A (CENP–A) was a significant independent prognostic marker for patients with ER–positive breast cancer not treated with systemic therapy but had limited predictive value in tamoxifen treated patients and was not predictive of response to neoadjuvant chemotherapy.

Please login or register to follow this author.
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

    Currently, there are no available articles.

Your Unread Messages in Oncology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Oncology Articles

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncologymore